D-4F, an apoA-I mimetic peptide, inhibits proliferation and tumorigenicity of epithelial ovarian cancer cells by upregulating the antioxidant enzyme MnSOD

International Journal of Cancer

Volumn 130, Issue 5, 2012, Pages 1071-1081

  Ganapathy, Ekambaram ^a   Su, Feng ^a   Meriwether, David ^a   Devarajan, Asokan ^a   Grijalva, Victor ^a   Gao, Feng ^a   Chattopadhyay, Arnab ^a   Anantharamaiah, G M ^b   Navab, Mohamad ^a   Fogelman, Alan M ^a   Reddy, Srinivasa T ^a   Farias Eisner, Robin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

animal models; apolipoprotein A I; epithelial ovarian cancer; mimetic peptides; MnSOD; oxidative stress

Indexed keywords

ANTINEOPLASTIC AGENT; APOLIPOPROTEIN A1; CARBONYL DERIVATIVE; D 4F; HYDROGEN PEROXIDE; MANGANESE SUPEROXIDE DISMUTASE; MESSENGER RNA; SHORT HAIRPIN RNA; SUPEROXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIOXIDANT STATUS; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GENE EXPRESSION; LIPID PEROXIDATION; METABOLIC PARAMETERS; MOUSE; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANIMALS; ANTIOXIDANTS; APOLIPOPROTEIN A-I; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HUMANS; MICE; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; UP-REGULATION;

EID: 84155169036     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26079     Document Type: Article

References (37)

1. Kim D, Hoory T, Monie A, Wu A, Hsueh WT, Pai SI, Hung CF,. Delivery of chemotherapeutic agents using drug-loaded irradiated tumor cells to treat murine ovarian tumors. J Biomed Sci 2010; 17: 61.
2. Kozak KR, Amneus MW, Pusey SM, Su F, Luong MN, Luong SA, Reddy ST, Farias-Eisner R,. Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosis. Proc Natl Acad Sci USA 2003; 100: 12343-8. (Pubitemid 37271562)
3. Kozak KR, Su F, Whitelegge JP, Faull K, Reddy S, Farias-Eisner R,. Characterization of serum biomarkers for detection of early stage ovarian cancer. Proteomics 2005; 5: 4589-96. (Pubitemid 41739936)
4. Su F, Lang J, Kumar A, Ng C, Hsieh B, Suchard MA, Reddy ST, Farias-Eisner R,. Validation of candidate serum ovarian cancer biomarkers for early detection. Biomark Insights 2007; 2: 369-75.
5. Su F, Kozak KR, Imaizumi S, Gao F, Amneus MW, Grijalva V, Ng C, Wagner A, Houg G, Farias-Eisner G, Anantharamaiah GM, Van Lenten BJ, et al. ApoA-I and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer. Proc Natl Acad Sci USA 2010; 107: 19997-20002.
6. Van Lenten BJ, Navab M, Anantharamaiah GM, Buga GM, Reddy ST, Fogelman AM,. Multiple indications for anti-inflammatory apolipoprotein mimetic peptides. Curr Opin Investig Drugs 2008; 9: 1157-62.
7. Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Fogelman AM,. Apo A-1 mimetic peptides as atheroprotective agents in murine models. Curr Drug Targets 2008; 9: 204-9. (Pubitemid 351843601)
8. Bloedon LT, Dunbar R, Duffy D, Pinell-Salles P, Norris R, DeGroot BJ, Movva R, Navab M, Fogelman AM, Rader DJ,. Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients. J Lipid Res 2008; 49: 1344-52.
9. Sherman CB, Peterson SJ, Frishman WH,. Apolipoprotein A-I mimetic peptides: a potential new therapy for the prevention of atherosclerosis. Cardiol Rev 2010; 18: 141-7.
10. Horiuchi A, Itoh K, Shimizu M, Nakai I, Yamazaki T, Kimura K, Suzuki A, Shiozawa I, Ueda N, Konishi I,. Toward understanding the natural history of ovarian carcinoma development: a clinicopathological approach. Gynecol Oncol 2003; 88: 309-17. (Pubitemid 36331983)
11. Delimaris I, Faviou E, Antonakos G, Stathopoulou E,.Zachari A, Dionyssiou-Asteriou A,. Oxidized LDL, serum oxidizability and serum lipid levels in patients with breast or ovarian cancer. Clin Biochem 2007; 40: 1129-34. (Pubitemid 47379323)
12. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M,. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Bio Interact 2006; 160: 1-40. (Pubitemid 43227479)
13. Dreher D, Junod AF,. Role of oxygen free radicals in cancer development. Eur J Cancer 1996; 32A: 30-8.
14. Ou Z, Ou J, Ackerman AW, Oldham KT, Pritchard KA, Jr,. L-4F, an apolipoprotein A-1 mimetic, restores nitric oxide and superoxide anion balance in low-density lipoprotein-treated endothelial cells. Circulation 2003; 107: 1520-24. (Pubitemid 36378491)
15. Van Lenten BJ, Wagner AC, Anantharamaiah GM, Navab M, Reddy ST, Buga GM, Fogelman AM,. Apolipoprotein A-I mimetic peptides. Curr Atheroscler Rep 2009; 11: 52-7.
16. Imaizumi S, Grijalva V, Navab M, Van Lenten BJ, Wagner AC, Anantharamiah GM, Fogelman AM, Reddy ST,. L-4F differentially alters plasma levels of oxidized fatty acids resulting in more anti-inflammatory HDL in mice. Drug Metab Lett 201; 4: 139-48.
17. Zhao H, Kalivendi S, Zhang H, Joseph J, Nithipatikom K, Vásquez-Vivar J, Kalyanaraman B,. Superoxide reacts with hydroethidine but forms a fluorescent product that is distinctly different from ethidium: potential implications in intracellular fluorescence detection of superoxide. Free Radic Biol Med 2003; 34: 1359-68. (Pubitemid 36570409)
18. Gao F, Vasquez SX, Su F, Roberts S, Shah N, Grijalva V, et al. L-5F, an apolipoprotein A-I mimetic peptide, inhibits tumor angiogenesis by suppressing activation of vascular endothelial growth factor/fibroblast growth factor signaling pathways. Integr Biol (Camb) 2011; 3: 479-89.
19. Kruger AL, Peterson S, Turkseven S, Kaminski PM, Zhang FF, Quan S, Wolin MS, Abraham NG,. D-4F induces heme oxygenase-1 and extracellular superoxide dismutase, decreases endothelial cell sloughing, and improves vascular reactivity in rat model of diabetes. Circulation 2005; 111: 3126-34. (Pubitemid 40847791)
20. Nguyen SD, Jeong TS, Sok DE,. Apolipoprotein A-I-mimetic peptides with antioxidant actions. Arch Biochem Biophys. 2006; 451: 34-42.
21. Peterson SJ, Husney D, Kruger AL, Olszanecki R, Ricci F, Rodella LF, Stacchiotti A, Rezzani R, McClung JA, Aronow WS, Ikehara S, Abraham NG,. Long-term treatment with the Apolipoprotein A1 mimetic peptide increases antioxidants and vascular repair in type I diabetic rats. J Pharmacol Exp Ther 2007; 322: 514-20. (Pubitemid 47105774)
22. Vaziri ND, Kim HJ, Moradi H, Farmand F, Navab K, Navab M, Hama S, Fogelman AM, Quiroz Y, Rodriguez-Iturbe B,. Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice. Nephrol Dial Transplant 2010; 25: 3525-34.
23. Burdon RH,. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic Biol Med 1995; 18: 775-794.
24. Dorward A, Sweet S, Moorehead R, Singh G,. Mitochondrial contributions to cancer cell physiology: redox balance, cell cycle, and drug resistance. J Bioenerg Biomembr 1997; 29: 385-92. (Pubitemid 27498418)
25. Schimmel M, Bauer G,. Proapoptotic and redox state-related signaling of reactive oxygen species generated by transformed fibroblasts. Oncogene 2002: 21: 5886-96. (Pubitemid 35007239)
26. Behrend L, Henderson G, Zwacka RM,. Reactive oxygen species in oncogenic transformation. Biochem. Soc Trans 2003; 31: 1441-4. (Pubitemid 38030996)
27. Turkseven S, Kruger A, Mingone CJ, Kaminski P, Inaba M, Rodella LF, Ikehara S, Wolin MS, Abraham NG,. Antioxidant mechanism of heme oxygenase-1 involves an increase in superoxide dismutase and catalase in experimental diabetes. Am J Physiol Heart Circ Physiol 2005; 289: H701-07. (Pubitemid 41129386)
28. Weydert CJ, Waugh TA, Ritchie JM, Iyer KS, Smith JL, Li L, Spitz DR, Oberley LW,. Overexpression of manganese or copper-zinc superoxide dismutase inhibits breast cancer growth. Free Radic Biol Med 2006; 41: 226-37. (Pubitemid 43928496)
29. Weydert CJ, Zhang Y, Sun W, Waugh TA, Teoh ML, Andringa KK, Aykin-Burns N, Spitz DR, Smith BJ, Oberley LW,. Increased oxidative stress created by adenoviral MnSOD or CuZnSOD plus BCNU (1,3-bis (2-chloroethyl)-1-nitrosourea) inhibits breast cancer cell growth. Free Radic Biol Med 2008; 44: 856-67.
30. Oberley LW,. Mechanism of the tumor suppressive effect of MnSOD overexpression. Biomed Pharmacother 2005; 59: 143-148. (Pubitemid 40603325)
31. Yuping Z, Smith BJ, Oberley LW,. Enzymatic activity is necessary for the tumor-suppressive effects of MnSOD. Antioxid Redox Signal 2006; 8: 1283-93. (Pubitemid 44182427)
32. Lebovitz RM, Zhang H, Vogel H, Cartwright J, Jr, Dionne L, Lu N, Huang S, Matzuk MM,. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc Natl Acad Sci USA 1996; 93: 9782-87. (Pubitemid 26296686)
33. Kondo T, Reaume AG, Huang TT, Murakami K, Carlson E, Chen S, Scott RW, Epstein CJ, Chan PH,. Edema formation exacerbates neurological and histological outcomes after focal cerebral ischemia in CuZn-superoxide dismutase knockout mutant mice. Acta Neurochir Suppl 1997; 70: 62-64. (Pubitemid 127502052)
34. Halliwell B,. Oxidative stress and cancer: have we moved forward? Biochem J 2007; 401: 1-11. (Pubitemid 46115897)
35. Czaja MJ, Schilsky ML, Xu Y, Schmiedeberg P, Compton A, Ridnour L, Oberley LW,. Induction of MnSOD gene expression in a hepatic model of TNF-α toxicity does not result in increased protein. Am J Physiol 1994; 266: G737-44.
36. Blum J, Fridovich I,. Inactivation of glutathione peroxidase by superoxide radical. Arch Biochem Biophys 1985; 240: 500-8. (Pubitemid 15250062)
37. Wang SY, Lewers KS, Bowman L, Ding M,. Antioxidant activities and anticancer cell proliferation properties of wild strawberrie. J Am Soc Hort Sci 2007; 132: 647-658. (Pubitemid 350194638)